Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rLH addition to rFSH for ovarian stimulation in women with poor ovarian reserve
NL-OMON31586Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of recombinant human follicle stimulating hormone and lutropin alfa in hypofertility and Diminished Ovarian Reserve (DOR) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Percentage of top-quality embryos. Planned start Feb 2008; status: not yet recruiting.
02
Drugs
recombinant human follicle stimulating hormonelutropin alfa
03
Conditions
hypofertilityDiminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NL-OMON31586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31586.